Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
Solution Structure of Nucleoprotein Domain 1 from the Emerging Yezo Virus. / Gladysheva, Anastasia V.; Yanshin, Alexey O.; Radchenko, Nikita S. и др.
в: International Journal of Molecular Sciences, Том 27, № 12, 5492, 18.06.2026.Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
}
TY - JOUR
T1 - Solution Structure of Nucleoprotein Domain 1 from the Emerging Yezo Virus
AU - Gladysheva, Anastasia V.
AU - Yanshin, Alexey O.
AU - Radchenko, Nikita S.
AU - Osinkina, Irina A.
AU - Ukladov, Egor O.
AU - Agafonov, Alexander P.
N1 - Gladysheva, A.V.; Yanshin, A.O.; Radchenko, N.S.; Osinkina, I.A.; Ukladov, E.O.; Agafonov, A.P. Solution Structure of Nucleoprotein Domain 1 from the Emerging Yezo Virus. Int. J. Mol. Sci. 2026, 27, 5492. https://doi.org/10.3390/ijms27125492 This research was funded by The Ministry of Science and Higher Education of the Russian Federation (agreement No. 075-15-2025-452) as part of the implementation of certain activities of the Federal Scientific and Technical Program for the Development of Synchrotron and Neutron Research and Research Infrastructure.
PY - 2026/6/18
Y1 - 2026/6/18
N2 - The Yezo virus (YEZV) is a recently discovered tick-borne orthonairovirus with pathogenic potential, causing acute febrile illness in humans. Viral nucleoproteins (N) play a key role in genome packaging, replication, and modulation of host immune responses, making their structural characterization essential for understanding viral pathogenesis and developing targeted countermeasures. However, the absence of structural data for YEZV proteins significantly hinders these efforts. This study presents the first solution structure of the YEZV N domain 1 (D1). A highly purified, soluble, tag-free recombinant YEZV N D1 was produced from the native sequence of the clinical YEZV isolate. The native-state conformation was resolved through an integrated approach combining size-exclusion chromatography coupled with small-angle X-ray scattering (SEC-SAXS), AlphaFold 3 structure prediction, and all-atom molecular dynamics simulations. The YEZV N D1 structure adopts a stable, predominantly α-helical globular fold that remains monomeric under near-physiological conditions. SEC-SAXS data show excellent agreement with computational models, revealing moderate conformational flexibility. The characterized recombinant YEZV N D1 and its first solution structure reported here providing essential insights into understanding of YEZV molecular architecture. These findings lay a foundation for rational serological assay development and structure-guided therapeutic design against this and other emerging orthonairoviruses.
AB - The Yezo virus (YEZV) is a recently discovered tick-borne orthonairovirus with pathogenic potential, causing acute febrile illness in humans. Viral nucleoproteins (N) play a key role in genome packaging, replication, and modulation of host immune responses, making their structural characterization essential for understanding viral pathogenesis and developing targeted countermeasures. However, the absence of structural data for YEZV proteins significantly hinders these efforts. This study presents the first solution structure of the YEZV N domain 1 (D1). A highly purified, soluble, tag-free recombinant YEZV N D1 was produced from the native sequence of the clinical YEZV isolate. The native-state conformation was resolved through an integrated approach combining size-exclusion chromatography coupled with small-angle X-ray scattering (SEC-SAXS), AlphaFold 3 structure prediction, and all-atom molecular dynamics simulations. The YEZV N D1 structure adopts a stable, predominantly α-helical globular fold that remains monomeric under near-physiological conditions. SEC-SAXS data show excellent agreement with computational models, revealing moderate conformational flexibility. The characterized recombinant YEZV N D1 and its first solution structure reported here providing essential insights into understanding of YEZV molecular architecture. These findings lay a foundation for rational serological assay development and structure-guided therapeutic design against this and other emerging orthonairoviruses.
KW - Ixodid tick
KW - Nairoviridae
KW - Orthonairovirus
KW - RNA virus
KW - protein structure
KW - ribonucleoprotein complex
KW - small-angle X-ray scattering
KW - tick-borne virus
KW - viral protein
KW - Иксодовый клещ
KW - клещевой вирус
KW - РНК-содержащий вирус
KW - Nairoviridae
KW - Orthonairovirus
KW - вирусный белок
KW - рибонуклеопротеиновый комплекс
KW - структура белка
KW - малоугловое рентгеновское рассеяние
UR - https://www.mendeley.com/catalogue/2202d4b8-6745-3846-ac48-18bcb9567ab6/
UR - https://www.scopus.com/pages/publications/105042835338
U2 - 10.3390/ijms27125492
DO - 10.3390/ijms27125492
M3 - Article
C2 - 42353207
VL - 27
JO - International Journal of Molecular Sciences
JF - International Journal of Molecular Sciences
SN - 1661-6596
IS - 12
M1 - 5492
ER -
ID: 85412353